文献速递焦虑、强迫与应激相关障碍心境障碍睡眠障碍

妊娠早期新暴露于苯二氮䓬类药物与自然流产风险的相关性

Association Between Incident Exposure to Benzodiazepines in Early Pregnancy and Risk of Spontaneous Abortion.
PubMed 文献 · JAMA Psychiatry · 2019-01-01

该嵌套病例对照研究基于魁北克妊娠队列(1998-2015年,442 066次妊娠),发现妊娠早期苯二氮䓬暴露与自然流产风险升高相关(调整OR 1.85,95%CI 1.61-2.12),短效与长效药物及所有具体药物均显示风险增加。

要点

  • 妊娠早期苯二氮䓬暴露者自然流产风险增加,调整OR为1.85(95%CI 1.61-2.12)。
  • 短效与长效苯二氮䓬类药物的风险相似,所有具体药物均与风险增加独立相关。
  • 临床应仔细评估妊娠早期处方苯二氮䓬的风险获益比,考虑非药物治疗替代。

核心结论

  • 妊娠早期新暴露于短效和长效苯二氮䓬类药物及所有具体药物均与自然流产风险增加相关。

研究设计与样本

  • 基于魁北克妊娠队列的嵌套病例对照研究,纳入1998年1月1日至2015年12月31日魁北克处方药保险计划覆盖的所有妊娠,每个病例随机匹配最多5个对照。

主要发现

  • 442 066次妊娠中27 149次(6.1%)以自然流产告终,自然流产孕妇平均年龄24.2(6.5)岁。
  • 自然流产妊娠中375次(1.4%)在妊娠早期暴露于苯二氮䓬,对照妊娠中788次(0.6%)暴露(粗OR 2.39;95%CI 2.10-2.73)。
  • 调整包括孕前心境和焦虑障碍等混杂因素后,妊娠早期苯二氮䓬暴露与自然流产风险增加相关(调整OR 1.85;95%CI 1.61-2.12)。
  • 短效苯二氮䓬暴露284例(调整OR 1.81;95%CI 1.55-2.12)与长效苯二氮䓬暴露98例(调整OR 1.73;95%CI 1.31-2.28)风险相似。
  • 所有苯二氮䓬具体药物均与自然流产风险增加独立相关(调整OR范围1.13-3.43)。

临床怎么用

  • 失眠、焦虑和心境障碍在孕期常见,临床医生应仔细评估妊娠早期处方苯二氮䓬的风险获益比,因存在替代非药物治疗。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Benzodiazepine use in early pregnancy is associated with spontaneous abortion (SA). However, to date, the association between specific benzodiazepine agent exposure and the risk of SA has not been examined. OBJECTIVE: To quantify the risk of SA associated with gestational benzodiazepine incident use by drug class, duration of action, and specific benzodiazepine agent. DESIGN, SETTING, AND PARTICIPANTS: This nested case-control study within the Quebec Pregnancy Cohort, Montreal, Quebec, Canada, includes all pregnancies covered by the Quebec Prescription Drug Insurance Plan from January 1, 1998, through December 31, 2015. Each case was randomly matched with up to 5 controls. Statistical analysis was performed from January 1, 1998, through December 31, 2015. EXPOSURES: Benzodiazepine exposure was defined as 1 or more filled prescriptions between the first day of the last menstrual period and the index date (the calendar date of the SA diagnosis). Benzodiazepine exposure was categorized by overall use, long- or short-acting benzodiazepine, and specific benzodiazepine agents. MAIN OUTCOMES AND MEASURES: Spontaneous abortion defined as a pregnancy loss between the beginning of the sixth week of gestation and the 19th completed week of gestation. Conditional logistic regression models were used to calculate odds ratios (OR) and 95% CIs. RESULTS: Of the 442 066 pregnancies included in the Quebec Pregnancy Cohort, 27 149 (6.1%) ended with SA, with a mean (SD) maternal age of 24.2 (6.5) years. Among pregnancies ending with SA, 375 (1.4%) were among women exposed to benzodiazepines in early pregnancy compared with 788 (0.6%) of the 134 305 matched control pregnancies (crude OR, 2.39; 95% CI, 2.10-2.73). Adjusting for potential confounders, including maternal mood and anxiety disorders before pregnancy, and compared with nonuse, benzodiazepine exposure in early pregnancy was associated with an increased risk of SA (adjusted OR, 1.85; 95% CI, 1.61-2.12). The risk was similar among pregnancies exposed to short-acting (284 exposed cases; adjusted OR, 1.81; 95% CI, 1.55-2.12) and long-acting (98 exposed cases; adjusted OR, 1.73; 95% CI, 1.31-2.28) benzodiazepines during early pregnancy. All benzodiazepine agents were independently associated with an increased risk of SA (range of adjusted ORs, 1.13-3.43). CONCLUSIONS AND RELEVANCE: An increased risk of SA was observed among early pregnancies with incident exposure to short- and long-acting benzodiazepines and all specific benzodiazepine agents during early pregnancy. Insomnia, anxiety, and mood disorders are prevalent during pregnancy; clinicians should carefully evaluate the risk-benefit ratio of prescribing benzodiazepines in early pregnancy since alternative nonpharmacologic treatments exist.

来源:JAMA Psychiatry,查看原文。版权归原作者所有。

引用

  1. Sheehy O, Zhao JP, Bérard A, et al. Association Between Incident Exposure to Benzodiazepines in Early Pregnancy and Risk of Spontaneous Abortion. JAMA Psychiatry. 2019. PMID: 31090881. doi:10.1001/jamapsychiatry.2019.0963

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。